Plasminogen Activator Inhibitor-1–Positive Platelet-Derived Extracellular Vesicles Predicts MACE and the Proinflammatory SMC Phenotype

Patients with established coronary artery disease remain at elevated risk of major adverse cardiac events. The goal of this study was to evaluate the utility of plasminogen activator inhibitor-1–positive platelet-derived extracellular vesicles as a biomarker for major adverse cardiac events and to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Richard G., Duchez, Anne-Claire, Simard, Trevor, Dhaliwal, Shan, Gillmore, Taylor, Di Santo, Pietro, Labinaz, Alisha, Ramirez, F. Daniel, Rasheed, Adil, Robichaud, Sabrina, Ouimet, Mireille, Short, Spencer, Clifford, Cole, Xiao, Fengxia, Lordkipanidzé, Marie, Burger, Dylan, Gadde, Suresh, Rayner, Katey J., Hibbert, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research - Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626902/
https://www.ncbi.nlm.nih.gov/pubmed/36337926
http://dx.doi.org/10.1016/j.jacbts.2022.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626902/
https://www.ncbi.nlm.nih.gov/pubmed/36337926
http://dx.doi.org/10.1016/j.jacbts.2022.05.002

Ejemplares similares